Cargando…
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study
Autores principales: | Levy, C., Dognon, N., Normandin, S., Duburcq, T., Gaudet, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U. and SEMICYUC.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617627/ http://dx.doi.org/10.1016/j.medine.2022.04.018 |
Ejemplares similares
-
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study
por: Levy, C., et al.
Publicado: (2023) -
Veno-venous ECMO indications: more than respiratory support
por: Blandino Ortiz, Aaron, et al.
Publicado: (2019) -
Endocan is a reliable biomarker during continuous renal replacement therapy
por: Hureau, Maxence, et al.
Publicado: (2019) -
Impact of acute renal failure on plasmatic levels of cleaved endocan
por: Gaudet, Alexandre, et al.
Publicado: (2019) -
The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome
por: Gaudet, Alexandre, et al.
Publicado: (2019)